Abbot Financial Management, Inc. Moderna, Inc. Transaction History

Abbot Financial Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $19,078 - $25,845	-161 Reduced 8.28%	1,783 $216,000
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $26,860 - $39,009	198 Added 11.34%	1,944 $298,000
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $206,691 - $366,729	1,746 New	1,746 $313,000
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $21,227 - $34,639	94 Added 5.92%	1,682 $427,000
Q3 2021 Nov 04, 2021	BUY	$221.9 - $484.47 $5,103 - $11,142	23 Added 1.47%	1,588 $611,000
Q2 2021 Aug 05, 2021	SELL	$129.91 - $234.98 $95,353 - $172,475	-734 Reduced 31.93%	1,565 $368,000
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $60,922 - $103,776	-558 Reduced 19.53%	2,299 $301,000
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $187,819 - $485,290	2,857 New	2,857 $298,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Abbot Financial Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Abbot Financial Management, Inc. with notifications on news.